Hester Biosciences Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Strong return on equity (ROE 15.9%)
- ✓Efficient capital deployment (ROCE 15.2%)
- ✓Attractively valued vs sector (P/E 38.8x vs industry 54.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
HESTERBIO · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% |
| FII | 0.43% | 0.43% | 0.52% | 0.61% | 0.59% | 0.87% |
| DII | — | — | — | — | 0.02% | 0.02% |
| Public | 45.83% | 45.84% | 45.74% | 45.66% | 45.65% | 45.38% |
Latest News
All news →Hester Biosciences publishes statutory notice in newspaper
Hester Biosciences has published a statutory notice in a newspaper as part of regulatory compliance. The filing is a routine corporate disclosure with no operational or financial implications. Such notices are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate_filing
Hester Biosciences publishes newspaper notice for compliance
*Hester Biosciences publishes newspaper notice for compliance.* This is a routine regulatory filing made in accordance with SEBI guidelines. The notice does not disclose any financial results or strategic developments. Such publications are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Compliance
Hester Biosciences publishes mandatory newspaper notice
*Hester Biosciences publishes mandatory newspaper notice.* This is a routine corporate disclosure as per regulatory requirements. No financial or operational impact is indicated. Such filings are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
Hester Biosciences sets dividend and meeting record date
*Hester Biosciences sets **14-Jul-2026** as record date for dividend and shareholder meeting.* The company has informed the exchange about the key date for entitlement and participation. This is a routine corporate action with no immediate financial impact. Investors holding shares on the record date will be eligible. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend
Hester Biosciences to hold shareholder meeting on July 21, 2026
*Hester Biosciences to hold shareholder meeting on July 21, 2026.* The event is scheduled for **July 21, 2026**, as per a corporate filing. No major announcements expected beyond routine agenda items. This is a standard procedural disclosure. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting
About Hester Biosciences Limited
Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania. It has partnered with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc. While operating across four broad verticals of Poultry Vaccines, Poultry Health Products, Animal Vaccines and Animal Health Products, the company provides services like seroprofiling kits and diagnostic labs for poultry flocks, and mastitis control programs for cattle.[1]
Healthcare · Pharmaceuticals & Biotechnology